Biography for Eric Palmer
Eric Palmer, Senior Editor
Eric Palmer is a business and technology journalist with more than three decades of prize-winning experience as a reporter and editor with daily, weekly, monthly and online publications. He was healthcare reporter for The Kansas City Star before becoming deputy business editor for the daily newspaper. He spent eight years as editor of The Kansas City Business Journal, which had a strong emphasis on the healthcare industry. On the personal side, he is an avid fly fisherman, cooks and collects wine, and likes to travel with his family. Eric is based in Kansas City and can be reached at firstname.lastname@example.org.
Articles by Eric Palmer
Bristol-Myers Squibb has reached an agreement to pay $80 million to 15 patients who were harmed or died during its failed trial for its experimental hepatitis C drug 094.
Chalk up another big win for Hal Barron and his R&D team extraordinaire at Genentech. The FDA today approved a new indication for Roche's ($RHHBY) cancer drug Avastin.
According to a posting today in the Federal Register, the FDA, which reports to HHS, now must determine whether there was any required clinical trial information that hasn't been submitted and give the "responsible party" 30 days to get the data into the federal clinical trials registry.
While it is not mentioned in the announcement, the drug-resistant superbug that has now killed 7 people infected at the National Institutes of Health Clinical Center had to be on the mind of FDA officials when they decided to form a task force to help push antibacterial drug development.